Enhancing Transthyretin Binding Affinity Prediction with a Consensus Model: Insights from the Tox24 Challenge
Chemical Research in Toxicology · 2025
DOI: 10.1021/acs.chemrestox.4c00560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2025. Verfasst von Xiaolin Pan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, New York University, New York, New York 10003, United States. Hauptthemen laut MEDLINE: Prealbumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, New York University, New York, New York 10003, United States.
- Simons Center for Computational Physical Chemistry at New York University, New York, New York 10003, United States.
- NYU-ECNU Center for Computational Chemistry at NYU Shanghai, Shanghai 200062, China.
ORCID-Profile: Xiaolin Pan, Yaowen Gu, Weijun Zhou, Yingkai Zhang
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Pan, X., Gu, Y., Zhou, W., & Zhang, Y. (2025). Enhancing Transthyretin Binding Affinity Prediction with a Consensus Model: Insights from the Tox24 Challenge. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00560
Vancouver
Pan X, Gu Y, Zhou W, Zhang Y. Enhancing Transthyretin Binding Affinity Prediction with a Consensus Model: Insights from the Tox24 Challenge. Chemical Research in Toxicology. 2025. doi:10.1021/acs.chemrestox.4c00560
BibTeX
@article{Pan2025,
author = {Pan, Xiaolin and Gu, Yaowen and Zhou, Weijun and Zhang, Yingkai},
title = {Enhancing Transthyretin Binding Affinity Prediction with a Consensus Model: Insights from the Tox24 Challenge},
journal = {Chemical Research in Toxicology},
year = {2025},
doi = {10.1021/acs.chemrestox.4c00560}
}
EUVIMED